MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $39.2M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.
Holders
50
Holders Change
-4
Holders Change %
-7.41%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
15
Closed
7
Calls
$232K
Puts
–
Net Calls
+$232K
Net Calls Change
+$171K
Top Buyers
Top Sellers
1 |
1
D.E. Shaw & Co
New York
|
$119K |
2 |
CC
2
Cannell & Co
New York
|
$0 |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$1K |
4 |
OAM
4
Oxford Asset Management
Oxford,
United Kingdom
|
$169K |
5 |
5
Goldman Sachs
New York
|
$0 |